OncoSil Medical Company Description

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe.

Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy.

OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

OncoSil Medical Limited

Country	Australia
Founded	2005
Industry	Medical Devices
Sector	Healthcare
CEO	Nigel Lange

Contact Details

Address: 7 Eden Park Drive Macquarie Park, 2113 Australia
Phone	61 2 8935 9629
Website	oncosil.com

Stock Details

Ticker Symbol	OSL
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000OSL3
SIC Code	2836

Key Executives

Name	Position
Nigel Lange	Chief Executive Officer, MD and Director